Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pediatric oral 14C-midazolam microdose pharmacokinetics study
NL-OMON44350Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of midazolam, sponsored by Erasmus MC. Primary endpoint: Apparent clearance of midazolam. Started Nov 2015; status: active, not recruiting.
02
Drugs
midazolam
Beyond the preview
Go deeper on NL-OMON44350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44350.